Vitamin D in Nephrotic Syndrome in Children

The Effect of Vitamin D on Nephrotic Syndrome in Children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130518013366N11

Enrollment

Registered

2019-03-11

Start date

2019-04-05

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome. Nephrotic syndrome

Interventions

Intervention 1: Intervention group: In these patients, in addition to the usual treatment of nephrotic syndrome (corticosteroid), we also used vitamin D, in which vitamin D is administered as an ampou

Eligibility

Sex/Gender

All

Age

No minimum to 15 Years

Inclusion criteria

Inclusion criteria: Affected to Nephrotic Syndrome

Exclusion criteria

Exclusion criteria: Patients who were not available during the next year and can not go to the center for follow-up treatment Patients with other underlying illnesses

Design outcomes

Primary

Measure	Time frame
Signs of Nephrotic Syndrome. Timepoint: Before treatment and 2 months after the administration of vitamin D. Method of measurement: Urine and blood test and clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahriar Hasanzadeh

Arak University of Medical Sciences

shahriarhasanzadeh@gmail.com+98 86 3313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026